During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the GvHD Hub spoke to Shernan G. Holtan, University of Minnesota, Minneapolis, US. We asked, What plasma short-chain fatty acids are predictors of response to graft-versus-host disease therapy?